Answers are grounded in this paper and cite their sources.
Restoring immune microenvironment homeostasis is critical for slowing osteoarthritis (OA) progression. However, the dense, avascular cartilage extracellular matrix restricts therapeutic access to deep inflammatory lesion sites. To address this challenge, we developed a self-propelled asymmetric yolk-shell nanomotor (mPDA-C@M), which overcomes this transport barrier through a dual drive strategy. By coupling cerium(IV) oxide–mediated catalytic propulsion with mesoporous polydopamine (mPDA)–enabled thermophoretic motion, the system achieves enhanced active transport, in which near-infrared irradiation reinforces directional movement and drives the nanomotor into deep cartilage. Beyond improved tissue access, mPDA-C@M modulates the osteoarthritic microenvironment by combining reactive oxygen species scavenging with mild photothermal stimulation. This synergistic effect up-regulates HSP70 expression and restores anabolic and catabolic balance through suppression of nuclear factor κB/mitogen-activated protein kinase inflammatory signaling. In rat and rabbit models, this dual strategy reduced cartilage degeneration, promoted matrix synthesis, and improved joint repair. These findings establish active-matrix traversal as a strategy for microenvironment-directed therapy in OA and other diffusion-limited inflammatory tissues.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: